                         SEQUENCE LISTING

<110>  L2 Diagnostics, LLC
 
<120>  ErbB PEPTIDE PHARMACEUTICAL AND VACCINE COMPOSITIONS AND 
       THERAPEUTIC USES THEREOF FOR CANCER

<130>  LDA-00225

<140>  PCT/US18/53046
<141>  2018-09-27

<150>  62/563850
<151>  2017-09-27

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  1

Ile Gln Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Cys 
1               5                   10                  15      


Pro Ala Gly 
            


<210>  2
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  2

Val Ala Cys Ala His Tyr Lys Asp Pro Pro Phe Cys Val Ala Arg Cys 
1               5                   10                  15      


Pro Ser Gly 
            


<210>  3
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  3

Ala Gln Cys Ala His Phe Arg Asp Gly Pro His Cys Val Ser Ser Cys 
1               5                   10                  15      


Pro His Gly 
            


<210>  4
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  4

Thr Lys Cys Ser His Phe Lys Asp Gly Pro Asn Cys Val Glu Lys Cys 
1               5                   10                  15      


Pro Asp Gly 
            


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Ala Met Asn Ile Thr Cys Thr Gly Arg Gly Pro Asp Asn Cys Ile Gln 
1               5                   10                  15      


Cys Ala His 
            


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

Ile Gln Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Ser 
1               5                   10                  15      


Pro Ala Gly 
            


<210>  7
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  7

Ile Gln Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Ser 
1               5                   10                  15      


Pro Ala Gly 
            


<210>  8
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  8

Ile Gln Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Ser 
1               5                   10                  15      


Pro Ala Gly Lys 
            20  


<210>  9
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  9

Ile Gln Cys Ala His Tyr Ile Asp Pro Pro His Cys Val Lys Thr Ser 
1               5                   10                  15      


Pro Ala Gly 
            


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  10

Ile Gln Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Ser 
1               5                   10                  15      


Pro Ala Gly 
            


<210>  11
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  11

Thr Gly Arg Gly Pro Asp Asn Cys Ile Gln Cys Ala His Tyr Ile Asp 
1               5                   10                  15      


Gly Pro His 
            


<210>  12
<211>  20
<212>  PRT
<213>  Mus musculus

<400>  12

Pro Ala Gly Ile Met Gly Glu Asn Asn Thr Leu Val Trp Lys Tyr Ala 
1               5                   10                  15      


Asp Ala Asn Asn 
            20  


<210>  13
<211>  20
<212>  PRT
<213>  Homo sapiens

<400>  13

Pro Ala Gly Val Met Gly Glu Asn Asn Thr Leu Val Trp Lys Tyr Ala 
1               5                   10                  15      


Asp Ala Gly His 
            20  


<210>  14
<211>  19
<212>  PRT
<213>  Mus musculus

<400>  14

Thr Leu Val Trp Lys Tyr Ala Asp Ala Asn Asn Val Cys His Leu Cys 
1               5                   10                  15      


His Ala Asn 
            


<210>  15
<211>  19
<212>  PRT
<213>  Canis lupus

<400>  15

Ile Lys Cys Ala His Tyr Ile Asp Gly Pro His Cys Val Lys Thr Cys 
1               5                   10                  15      


Pro Ala Gly 
            


